Edward V. Nunes

ORCID: 0000-0002-2055-3425

Also affiliated with New York State Department of State, Columbia University Irving Medical Center, NYU Langone Health, Anna Needs Neuroblastoma Answers, Columbia University, Penn State Milton S. Hershey Medical Center

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.309Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type

Addiction(2024)10.1111/add.16659

Top 54%

0.309DataRank

Top 54%5 citations

Rebecca A. Raciborski, Matthew Nowak, Mahip Acharya, Edward V. Nunes, Theresa Winhusen +1 more

Papers

Driven by 28 papers — median percentile 46. Top paper: “Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use”.

Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.17377

N/A

0.911DataRank · unranked

23 citations

Sandra D. Comer, Michelle R. Lofwall, Sharon Walsh, Stefan Peterson, Fredrik Tiberg +3 more

Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term SM) communities study

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.109804

N/A

0.870DataRank · unranked

46 citations

Edward V. Nunes, Sylvia Tan, Patricia R. Freeman, Alexander Y. Walley, Michelle R. Lofwall +11 more

COVID-19 related substance use services policy changes: Policymaker perspectives on policy development & implementation

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108550

N/A

0.546DataRank · unranked

37 citations

Aimee Campbell, Timothy Hunt, Jessica K. Johnson, Amar Mandavia, Michael Chaple +8 more

Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.40006

N/A

0.469DataRank · unranked

14 citations

Rouba Chahine, Jennifer Villani, Redonna Chandler, Daniel J. Feaster, Svetla Slavova +41 more

Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR16) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial

Neuropsychiatric Disease and Treatment(2023)10.2147/ndt.s406909

N/A

0.438DataRank · unranked

14 citations

Alexandra A. Kulikova, Taryn L. Mayes, Karabi Nandy, Thomas Carmody, Gavin Bart +6 more

Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type

Addiction(2024)10.1111/add.16659

Top 54%

0.309DataRank

Top 54%5 citations

Rebecca A. Raciborski, Matthew Nowak, Mahip Acharya, Edward V. Nunes, Theresa Winhusen +1 more

Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorder

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.110899

N/A

0.269DataRank · unranked

5 citations

Sabrina L Smiley, Phillip O. Coffin, Thomas Carmody, Frances R. Levin, Edward V. Nunes +3 more

Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111286

N/A

0.249DataRank · unranked

4 citations

Christian Douglas, Joel G. Sprunger, Aimee Campbell, Redonna Chandler, Anindita Dasgupta +37 more

Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107148

N/A

0.216DataRank · unranked

3 citations

Matisyahu Shulman, Onumara Opara, Kenzie M. Potter, Delia Voronca, Hiwot M. Tafessu +12 more

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports(2022)10.1016/j.dadr.2022.100100

N/A

0.165DataRank · unranked

2 citations

Tse‐Hwei Choo, Dikla Shmueli‐Blumberg, Martina Pavlicová, Jacquie King, Marc Fishman +9 more

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol

Research Square(2025)10.21203/rs.3.rs-6666196/v1

N/A

0.118DataRank · unranked

1 citations

Kirsten Shuler, Sarah Kawasaki, Eric Weintraub, Aaron D. Greenblatt, Mat Kladney +10 more

Association of Baseline Fentanyl Use and Opioid Withdrawal Symptoms During Inpatient Buprenorphine Initiation in a Large Multisite Detoxification Trial

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110457

N/A

0DataRank · unranked

0 citations

Miranda Greiner, Mei‐Chen Hu, Onumara Opara, Kenzie M. Potter, Kaitlyn Ohrtman +3 more

Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial

Journal of Addiction Medicine(2025)10.1097/adm.0000000000001484

N/A

0DataRank · unranked

3 citations

Edward V. Nunes, Sharon Walsh, Genie L. Bailey, Michael Frost, Natalie R. Budilovsky-Kelley +6 more

Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?

AJPM Focus(2025)10.1016/j.focus.2025.100371

N/A

0DataRank · unranked

1 citations

Douglas R. Oyler, Denise C. Babineau, Jennifer Villani, Redonna K. Chandler, Patricia R. Freeman +39 more

Development of the Brief Stigma and Perceptions Questionnaire for Pharmacists: A Confirmatory Factor Analysis Approach in New York State Counties Enrolled in the Healing Communities Study

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112166

N/A

0DataRank · unranked

0 citations

Kyle Grealis, Nabila El–Bassel, David W. Lounsbury, Nishita Dsouza, Jennifer Bhuiyan +18 more

The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209835

N/A

0DataRank · unranked

0 citations

Joel G. Sprunger, Timothy Hunt, JaNae Holloway, Redonna K. Chandler, Bridget Freisthler +28 more

The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.02.005

N/A

0DataRank · unranked

78 citations

Aimee Campbell, Cynthia I. Campbell, Ching-Hua Chen, Emre Ertin, Udi E. Ghitza +20 more

A clinical trial loses access to some of its experimental treatment conditions: What can be done?

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209854

N/A

0DataRank · unranked

0 citations

Matisyahu Shulman, R D Weiss, Patricia Novo, Scott E. Provost, Michael Otterstatter +4 more

Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adults

Addictive Behaviors(2020)10.1016/j.addbeh.2020.106514

N/A

0DataRank · unranked

7 citations

LaTrice Montgomery, A. Kathleen Burlew, Aimee Campbell, Jennifer Scodes, Martina Pavlicová +3 more

Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108489

N/A

0DataRank · unranked

7 citations

Theresa Winhusen, Jennifer Scodes, Martina Pavlicová, Dylanne Twitty, Aimee Campbell +4 more

Impacts of the New York State COVID‐19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder

Addiction(2022)10.1111/add.16087

N/A

0DataRank · unranked

2 citations

Daniel J. Feaster, Raymond R. Balise, James W. Quinn, Edward V. Nunes, Louisa Gilbert +3 more

Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial

Journal of Addiction Medicine(2023)10.1097/adm.0000000000001136

N/A

0DataRank · unranked

13 citations

Johnathan Nunez, Prerana Roth, Meredith Schade, Michelle Strong, Cynthia Frank +6 more

Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinence

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.109918

N/A

0DataRank · unranked

3 citations

Mei‐Chen Hu, Edward V. Nunes, Aimee Campbell, Laura Brandt

Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

Addiction(2024)10.1111/add.16630

N/A

0DataRank · unranked

11 citations

Edward V. Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A. Stuart +2 more

Development of a brief stigma and perceptions questionnaire for pharmacists: An exploratory factor analysis approach in New York state counties enrolled in the healing communities study

Journal of Substance Use and Addiction Treatment(2024)10.1016/j.josat.2024.209566

N/A

0DataRank · unranked

3 citations

Kyle Grealis, Nabila El–Bassel, David W. Lounsbury, Nishita Dsouza, Jennifer Bhuiyan +23 more

Optimizing Contingency Management with Reinforcement Learning

medRxiv(2024)10.1101/2024.03.28.24305031

N/A

0DataRank · unranked

2 citations

Laura Brandt, Ying Kuen Cheung, Edward V. Nunes, John M. Roll, Sean X. Luo +2 more

WITHDRAWN: Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

medRxiv(2024)10.1101/2024.01.24.24301555

N/A

0DataRank · unranked

1 citations

Edward V. Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A. Stuart +2 more

Patient Characteristics of Fentanyl Positive Individuals With Opioid Use Disorder

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110398

N/A

0DataRank · unranked

0 citations

Mei‐Chen Hu, Matisyahu Shulman, Kathryn Hefner, Onumara Opara, Kenzie M. Potter +5 more

Edward V. Nunes

Indexed papers

Top data-sharing exemplar

Papers